These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34431218)

  • 1. The inflammatory bowel disease disk application: A platform to assess patients' priorities and expectations from treatment.
    Naftali T; Richter V; Mari A; Khoury T; Shirin H; Broide E
    J Dig Dis; 2021 Oct; 22(10):582-589. PubMed ID: 34431218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do inflammatory bowel disease patient preferences from treatment outcomes differ by ethnicity and gender? A cross-sectional observational study.
    Naftali T; Richter V; Mari A; Khoury T; Shirin H; Broide E
    World J Clin Cases; 2022 Dec; 10(35):12899-12908. PubMed ID: 36569023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health priorities in adolescents with inflammatory bowel disease: physicians' versus patients' perspectives.
    Cervesi C; Battistutta S; Martelossi S; Ronfani L; Ventura A
    J Pediatr Gastroenterol Nutr; 2013 Jul; 57(1):39-42. PubMed ID: 23403446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.
    Pittet VEH; Maillard MH; Simonson T; Fournier N; Rogler G; Michetti P;
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2050-2059.e1. PubMed ID: 30471455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with Inflammatory Bowel Disease Have Heterogeneous Treatment Preferences That Are Largely Determined by the Avoidance of Abdominal Pain and Side Effects [P-POWER IBD Study].
    Louis E; Siegel CA; James B; Heidenreich S; Krucien N; Ghosh S
    J Crohns Colitis; 2023 Mar; 17(2):231-239. PubMed ID: 36130188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Pre-emptive Discussions of Biologic Treatment: Results from an Openness and Preference Survey of Inflammatory Bowel Disease Patients and Their Prescribers.
    Kariburyo MF; Xie L; Teeple A; Tan H; Ingham M
    Adv Ther; 2017 Jun; 34(6):1398-1410. PubMed ID: 28484953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.
    Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y
    J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire survey.
    Ueno F; Nakayama Y; Hagiwara E; Kurimoto S; Hibi T
    J Gastroenterol; 2017 May; 52(5):555-567. PubMed ID: 27470433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a questionnaire to test Chinese patients' knowledge of inflammatory bowel disease.
    Xie H; Zhang J; Liu C; Yang B; Dong W
    Sci Rep; 2023 Apr; 13(1):7061. PubMed ID: 37121924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type.
    Griffiths AM; Nicholas D; Smith C; Munk M; Stephens D; Durno C; Sherman PM
    J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):S46-52. PubMed ID: 10204526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients.
    Morishige R; Nakajima H; Yoshizawa K; Mahlich J; Sruamsiri R
    Adv Ther; 2017 Jan; 33(12):2242-2256. PubMed ID: 27807816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IBD-Disk as a tool estimating the prevalence of inflammatory bowel disease-related disability and associated influencing factors in Saudi Arabia: A cross-sectional study.
    Meeralam Y; Al-Zanbagi AB; Al Saedi M; Alharthi W; Sabbahi HA; Alhejaili T; Shariff MK
    Saudi J Gastroenterol; 2023; 29(5):309-315. PubMed ID: 37787349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with quality of care in inflammatory bowel diseases: a view from patient's side using the IQCARO quality of care decalogue.
    Casellas F; Calvet X; Carpio D; Vera I; Saldaña R; Mínguez M; Marín L; Juliá B;
    BMC Gastroenterol; 2021 Oct; 21(1):412. PubMed ID: 34715812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD Centre.
    Gonczi L; Kurti Z; Verdon C; Reinglas J; Kohen R; Morin I; Chavez K; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
    J Crohns Colitis; 2019 Sep; 13(9):1138-1147. PubMed ID: 30793162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Bowel Disease Patients' Participation, Attitude and Preferences Toward Exercise.
    Chae J; Yang HI; Kim B; Park SJ; Jeon JY
    Int J Sports Med; 2016 Jul; 37(8):665-70. PubMed ID: 27191208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia.
    AlRuthia Y; Almadi M; Aljebreen A; Azzam N; Alsharif W; Alrasheed H; Almuaythir G; Saeed M; HajkhderMullaissa B; Alharbi O
    J Med Econ; 2020 Oct; 23(10):1102-1110. PubMed ID: 32619388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.